title: [In the treatment of mCRPC, the question is to administer the right molecule to the right patient, at the right time].
authors.forename: Stéphane
authors.initials: S
authors.lastname: Oudard
mesh_terms: D000726:Androgen Antagonists / Q000627:therapeutic use; D019008:Drug Resistance, Neoplasm; D006801:Humans; D008297:Male; D009362:Neoplasm Metastasis; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000473:pathology; D013997:Time Factors
chemical_list: D000726:Androgen Antagonists